glp 1 and bowel movements GLP-1 constipation relief: proven strategies that actually work GLP-1 SOS™ Digestive Support for

Most once-weekly GLP-1 medications have a half-life of approximately seven days

The percentages of participants who experienced AE leading to treatment discontinuation as well as of those who experienced gastrointestinal AE with oral semaglutide 50 mg (Tables 2 and 3) were similar to those observed with subcutaneous semaglutide 2.4 mg (in STEP-1 and STEP-2 trials 67% discontinued treatment due to AE, 3444% experienced nausea, 2132% diarrhoea and 2225% vomiting) [11, 29]

Speak to your GP or diabetes care team about your concernsthey can help you find management strategies or adjust your treatment plan whilst maintaining effective glycaemic control

Patients with a history of pancreatitis should be considered for alternative agents when possible

LegitScript Certification and Safety Overview In a GLP-1 telehealth market that attracted significant regulatory scrutiny in early 2026 with the FDA issuing warning letters to more than 30 platforms for marketing violations legitimacy verification is a reasonable and important question for any patient evaluating a new provider

Every patient receives compounded formulations prescribed specifically for their health profile and conveniently delivered directly to their door